The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2026

Filed:

Jan. 14, 2025
Applicant:

National University Corporation Kobe University, Hyogo, JP;

Inventors:

Takashi Aoi, Hyogo, JP;

Nobuyuki Murai, Hyogo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 40/42 (2025.01); A61K 40/11 (2025.01); A61K 40/32 (2025.01); A61P 35/00 (2006.01); C07K 14/725 (2006.01); C12N 5/00 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 40/421 (2025.01); A61K 40/11 (2025.01); A61K 40/32 (2025.01); A61K 40/42 (2025.01); A61P 35/00 (2018.01); C07K 14/7051 (2013.01); C12N 5/0037 (2013.01); C12N 5/0636 (2013.01);
Abstract

Provided is a γδ T cell for securing the purity and number of cells sufficient for treatment. Also provided is a method of generating the γδ T cell. More specifically, provided are homogeneous γδ T cells excellent in that the γδ T cells are not affected by exhaustion of the cells. The foregoing is achieved by γδ T cells obtained by subjecting induced pluripotent stem cells (iPS cells) to differentiation induction treatment. Specifically, the foregoing is achieved by γδ T cells generated by subjecting iPS cells having a rearranged γδ TCR gene (γδ TCR-type iPS cells) to differentiation induction treatment. According to the method of generating the γδ T cell of the present invention, there can be provided γδ T cells and a cell population of γδT cells that have an excellent function of having antigen-specific cytotoxic activity in an MHC-unrestricted manner, and that are more homogeneous and have a higher effect than γδ T cells separated from peripheral blood.


Find Patent Forward Citations

Quick Actions:

Aoi, Takashi. (2026). Gamma delta t cells derived from induced pluripotent stem cells, and production method therefor (U.S. Patent No. 12576149). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12576149

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…